Mergers & Acquisitions
Pfizer and Allergan May Have to Call-Off Their $160 Billion Merger
Pfizer and Allergan will have to scrap the merger deal following the new regulation from Treasury Department to stop the U.S. company moving overseas.
China’s Anbang Acquired Allianz’s South Korea Operations After Dropping Its Bid for Starwood Hotels
Anbang Insurance is acquiring Allianz’s operations in South Korea after dropping its offer to buy Starwood hotels. The deal is waiting for approval from South Korea’s financial regulator.
Pfizer to end merger deal with Allergan as new rules frighten corporate inversions
Pfizer, a US-based drug company, is said to dismiss its merger deal with Allergan. The US drugmaker wants to quit from the $160 billion merger deal since Washington authorities set new rules, making corporate inversions harder.
Halliburton Acquisition of Baker Hughes Faces a Legal Obstacle
United States Justice Department has prepared a lawsuit to block acquisition of Baker Hughes. Halliburton took over the company in November 2014.